WILMINGTON, October 17, 2026 — A Delaware jury found Arm in breach of its chip architecture license with Qualcomm, triggering a selloff in semiconductor stocks and raising scrutiny on TSMC’s foundry position.
Verdict Triggers Immediate Market Reaction
Arm shares fell 5% to $232.22 during afternoon trading, according to 247 Wall St. Advanced Micro Devices also dropped 5% to $534.29, mirroring Arm’s decline. Taiwan Semiconductor Manufacturing shares slipped 2% to $412.45, a softer decline than Arm or AMD but still part of a broader sector pullback. The iShares Semiconductor ETF fell 3%, while the Invesco QQQ Trust declined 2%. Qualcomm, the opposing party in the case, saw its shares briefly spike 2% following the verdict.
License Agreement at Core of Arm’s Business Model
Arm’s business relies on licensing chip architecture and core designs, then earning royalties as partners ship products built on them, as noted in 247 Wall St’s reporting. Each license agreement is central to its revenue stream, which includes upfront fees and per-chip royalties. Qualcomm is one of Arm’s licensees, so the verdict directly impacts the royalty income that underpins Arm’s growth outlook. The jury found Arm breached its chip architecture license agreement with Qualcomm, interfered with Qualcomm’s relationship with a customer, and violated California’s unfair competition law. Arm prevailed on a separate technology licensing claim, but the overall outcome was negative.
TSMC’s Foundry Role Comes Under Review
TSMC manufactures chips for Arm licensees, including Qualcomm’s Snapdragon processors, which power a wide range of devices, according to both 247 Wall St and AOL. While TSMC does not design the chips it produces, its position as the dominant foundry supplier means any disruption in Arm’s licensing ecosystem could affect demand for its manufacturing services. The verdict adds pressure to an already strained semiconductor sector, where supply chain dependencies and IP licensing tensions are under close watch.
Upcoming Bench Trial Looms
Closing arguments in a related bench trial over Arm’s licensing of its newest architecture are scheduled for next week, as reported by 247 Wall St and AOL. In a bench trial, a judge will decide the outcome, meaning Arm faces a second ruling on how it licenses its latest designs. The legal dispute originated from Arm’s 2022 lawsuit against Qualcomm over alleged contract violations following Qualcomm’s $1.4 billion acquisition of chip startup Nuvia. Qualcomm won a jury verdict in December 2024, upheld in September 2025, which Arm appealed. In the current case, Qualcomm accused Arm of withholding software patches and chip-testing tools needed to verify its custom Oryon CPU cores. Qualcomm also alleged Arm leaked a 2024 license-termination warning letter to Bloomberg, damaging its business reputation and costing approximately $170 million in a potential deal with Meta Platforms. The verdict, dated October 13, 2026, represents another legal setback for Arm in its ongoing dispute with Qualcomm.
Qualcomm’s Allegations of Deliberate Harm and Financial Impact
The jury’s verdict against Arm included findings that Qualcomm alleged were particularly damaging to its business operations. According to Qualcomm’s statement, the ruling confirmed that Arm had withheld critical software patches and chip-testing tools necessary for Qualcomm to validate its custom Oryon CPU cores. These tools, which Arm was obligated to provide under the licensing agreement, were central to Qualcomm’s ability to ensure the performance and compatibility of its newest processor designs. The jury’s decision that Arm intentionally disrupted Qualcomm’s relationship with a customer further underscored the severity of the alleged misconduct, as Qualcomm claimed this interference directly threatened its ability to secure high-profile contracts.
Qualcomm’s legal team also highlighted a specific financial blow tied to Arm’s actions. The company alleged that Arm deliberately leaked a 2024 warning letter threatening to terminate the license agreement to *Bloomberg*, a move Qualcomm said damaged its reputation and derailed a potential $170 million deal with Meta Platforms. The jury’s ruling on California’s unfair competition law appeared to validate Qualcomm’s claim that Arm’s conduct was not only a breach of contract but also an attempt to undermine a competitor’s business prospects through deceptive practices. The financial stakes were further emphasized by the licensing agreement’s duration—extending through 2033—which made the dispute a long-term threat to Qualcomm’s revenue stream.
While the verdict did not specify whether damages would be awarded, Qualcomm’s post-ruling statement framed the outcome as a victory for innovation and fair competition in the semiconductor industry. The company’s shares briefly surged 2% on the news, reflecting investor confidence in its legal position. The ruling also revived earlier tensions from Qualcomm’s 2024 jury win, which had been upheld in September 2025 after Arm’s appeal. The ongoing litigation, now including a bench trial over Arm’s newest architecture licensing, suggests that the dispute’s resolution may hinge on broader questions about how Arm enforces its licensing terms—and whether its actions could set a precedent for other licensees challenging its practices.
Sources
- Arm and AMD Fall 5% as Qualcomm Verdict Adds to Chip Selloff; Taiwan Semiconductor Slips
- Arm and AMD Fall 5% as Qualcomm Verdict Adds to Chip Selloff; Taiwan Semiconductor Slips – AOL
- Arm shares fall after jury rules in favor of Qualcomm in license dispute
Photo: Cmglee (CC BY-SA 3.0)
